Adarza BioSystems Revenue and Competitors

Maryland Heights,

Location

$64.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Adarza BioSystems's estimated annual revenue is currently $930k per year.(i)
  • Adarza BioSystems's estimated revenue per employee is $77,500
  • Adarza BioSystems's total funding is $64.2M.

Employee Data

  • Adarza BioSystems has 12 Employees.(i)
  • Adarza BioSystems grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$15.3M99-49%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.5M29-6%N/AN/A
#10
$9.6M62-7%N/AN/A
Add Company

The Arrayed Imaging Reflectometry (AIR) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The companyᅢᄁ¬ツᆲ¬トᄁs unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarzaᅢᄁ¬ツᆲ¬トᄁs first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research.

keywords:N/A

$64.2M

Total Funding

12

Number of Employees

$930k

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Adarza BioSystems News

2017-01-23 - Adarza BioSystems Closes $17M Series C Financing

Adarza BioSystems, Inc., a Rochester, N.Y. and St. Louis, Mo.-based developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and in vitro diagnostics customers, closed a $17M Series C financing. The round was led by 3×5 RiverVes ...

2017-01-23 - Adarza BioSystems Raises $17M Series C

Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final ...

2016-03-22 - Adarza BioSystems Closes $5M Series B Financing

Adarza BioSystems, a West Henrietta, NY- and St. Peters, MO-based provider of label-free, multiplex assays, closed a $5m Series B financing. Backers included Cultivation Capital, Lewis and Clark Ventures and Siemens’ venture capital arm. The company intends to use the funds to expand productio ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M17-11%N/A
#2
$3.3M17-15%N/A
#3
$4.2M22-4%N/A
#4
$2.3M23-60%N/A
#5
$5.3M23-8%N/A